Fox Chase Cancer Ctr. — Philadelphia, Pennsylvania

Fox Chase Cancer Ctr. is a clinical research site located in Philadelphia, Pennsylvania, United States 19111.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Ctr. has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Adenocarcinoma.

Sponsors: AmpliMed Corporation.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Ctr.?

Fox Chase Cancer Ctr. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Ctr. conducted?

Fox Chase Cancer Ctr. has 1 clinical trials on record. Their work covers Pancreatic Adenocarcinoma.

Is Fox Chase Cancer Ctr. accredited by Crixeo Health?

Fox Chase Cancer Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.